Factors Predicting the Outcomes of Second-Line Therapy for Chronic Immune Thrombocytopenia
Last updated: 27 Apr 2025
10.21608/mjcu.2025.422940
Immune thrombocytopenia, TPO-RAs, Splenec-tomy
SARA E. ABD EL-GHANI, M.D.1,2; ESLAM AYMAN M. AHMED, M.Sc.3;
GEORGE B. BESHARA, M.D.4; NOHA M. EL-HUSSEINY, M.D.1,2;
MARWA SALAH MOHAMED, M.D.1,2 and ASMAA M. ABD ELHAMEED, M.D.1,3
.
The Department of Internal Medicine, Clinical Hematology Unit, Faculty of Medicine, Cairo University1, Hematology Department, Armed Forces College of Medicine (AFCM)2, Internal Medicine Department, Armed Forces College of Medicine (AFCM)3 and Hematology Department, Maadi Military Complex4
93
03
55142
2025-03-01
2025-04-17
2025-03-01
115
124
0045-3803
2536-9806
https://mjcu.journals.ekb.eg/article_422940.html
http://journals.ekb.eg?_action=service&article_code=422940
422,940
Original Article
263
Journal
The Medical Journal of Cairo University
https://mjcu.journals.ekb.eg/
Factors Predicting the Outcomes of Second-Line Therapy for Chronic Immune Thrombocytopenia
Details
Type
Article
Created At
27 Apr 2025